A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A20/Tumor Necrosis Factor α-Induced Protein 3 in Immune Cells Controls Development of Autoinflammation and Autoimmunity: Lessons from Mouse Models
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-02-21
DOI
10.3389/fimmu.2018.00104
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease
- (2018) Florence A Aeschlimann et al. ANNALS OF THE RHEUMATIC DISEASES
- Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders
- (2018) Tomonori Kadowaki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Haploinsufficiency of TNFAIP3 ( A20 ) by germline mutation is involved in autoimmune lymphoproliferative syndrome
- (2017) Masatoshi Takagi et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development of autoantibodies precedes clinical manifestations of autoimmune diseases: A comprehensive review
- (2017) Wen-Tao Ma et al. JOURNAL OF AUTOIMMUNITY
- A20 Restrains Thymic Regulatory T Cell Development
- (2017) Julius Clemens Fischer et al. JOURNAL OF IMMUNOLOGY
- Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
- (2017) Paul M Ridker et al. LANCET
- Current and emerging therapeutic targets for IBD
- (2017) Markus F. Neurath Nature Reviews Gastroenterology & Hepatology
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypomorphic A20 expression confers susceptibility to psoriasis
- (2017) Anri Aki et al. PLoS One
- A Japanese family case with juvenile onset Behçet's disease caused by TNFAIP3 mutation
- (2017) Hidenori Ohnishi et al. ALLERGOLOGY INTERNATIONAL
- A Brief History of IL-1 and IL-1 Ra in Rheumatology
- (2017) Jean-Michel Dayer et al. Frontiers in Pharmacology
- The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases
- (2017) Carlos de Torre-Minguela et al. Frontiers in Immunology
- NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases
- (2017) Ivona Aksentijevich et al. Frontiers in Immunology
- rs10499194 polymorphism in the tumor necrosis factor-α inducible protein 3 (TNFAIP3) gene is associated with type-1 autoimmune hepatitis risk in Chinese Han population
- (2017) Enbin Xu et al. PLoS One
- A20 inhibition of STAT1 expression in myeloid cells: a novel endogenous regulatory mechanism preventing development of enthesitis
- (2016) Katelijne De Wilde et al. ANNALS OF THE RHEUMATIC DISEASES
- Association of the polymorphisms of TRAF1 (rs10818488) and TNFAIP3 (rs2230926) with rheumatoid arthritis and systemic lupus erythematosus and their relationship to disease activity among Egyptian patients
- (2016) Mai Moaaz et al. Central European Journal of Immunology
- TALEN-mediated enhancer knockout influences TNFAIP3 gene expression and mimics a molecular phenotype associated with systemic lupus erythematosus
- (2016) S Wang et al. GENES AND IMMUNITY
- Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance
- (2016) Heekyong R. Bae et al. HEPATOLOGY
- The burgeoning field of innate immune-mediated disease and autoinflammation
- (2016) Daniel Peckham et al. JOURNAL OF PATHOLOGY
- Reactive oxygen homeostasis – the balance for preventing autoimmunity
- (2016) D Kienhöfer et al. LUPUS
- Different tissue phagocytes sample apoptotic cells to direct distinct homeostasis programs
- (2016) Ryan J. Cummings et al. NATURE
- Inflammatory Th1 and Th17 in the Intestine Are Each Driven by Functionally Specialized Dendritic Cells with Distinct Requirements for MyD88
- (2016) Jie Liang et al. Cell Reports
- A20 Curtails Primary but Augments Secondary CD8+ T Cell Responses in Intracellular Bacterial Infection
- (2016) Sissy Just et al. Scientific Reports
- TNFAIP3 promotes survival of CD4 T cells by restricting MTOR and promoting autophagy
- (2015) Yu Matsuzawa et al. Autophagy
- TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils
- (2015) S. Indhumathi et al. BRITISH JOURNAL OF BIOMEDICAL SCIENCE
- Correlation of Biomarker Expression in Colonic Mucosa with Disease Phenotype in Crohn’s Disease and Ulcerative Colitis
- (2015) Maria E. C. Bruno et al. DIGESTIVE DISEASES AND SCIENCES
- A20 Restricts Ubiquitination of Pro-Interleukin-1β Protein Complexes and Suppresses NLRP3 Inflammasome Activity
- (2015) Bao H. Duong et al. IMMUNITY
- Orphan Nuclear Receptor ERRα Controls Macrophage Metabolic Signaling and A20 Expression to Negatively Regulate TLR-Induced Inflammation
- (2015) Jae-Min Yuk et al. IMMUNITY
- GM-CSF Mouse Bone Marrow Cultures Comprise a Heterogeneous Population of CD11c+MHCII+ Macrophages and Dendritic Cells
- (2015) Julie Helft et al. IMMUNITY
- Characteristics of A20 gene polymorphisms and clinical significance in patients with rheumatoid arthritis
- (2015) Lihua Zhu et al. Journal of Translational Medicine
- Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation
- (2015) Ingrid E. Wertz et al. NATURE
- Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease
- (2015) Qing Zhou et al. NATURE GENETICS
- The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis
- (2015) Michio Onizawa et al. NATURE IMMUNOLOGY
- RC3H1 post-transcriptionally regulates A20 mRNA and modulates the activity of the IKK/NF-κB pathway
- (2015) Yasuhiro Murakawa et al. Nature Communications
- International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways
- (2015) Heather J. Cordell et al. Nature Communications
- Advances in understanding the role of type I interferons in systemic lupus erythematosus
- (2014) Mary K. Crow CURRENT OPINION IN RHEUMATOLOGY
- A20 expression in dendritic cells protects mice from LPS-induced mortality
- (2014) Nguyen Thi Xuan et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Gender differences in autoimmune disease
- (2014) S.T. Ngo et al. FRONTIERS IN NEUROENDOCRINOLOGY
- Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1
- (2014) Ynto S. de Boer et al. GASTROENTEROLOGY
- A20 deficiency causes spontaneous neuroinflammation in mice
- (2014) Renata Guedes et al. Journal of Neuroinflammation
- Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis
- (2014) Lieselotte Vande Walle et al. NATURE
- Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor–independent TCR signaling hub
- (2014) Romain Roncagalli et al. NATURE IMMUNOLOGY
- The transcription factor DREAM represses the deubiquitinase A20 and mediates inflammation
- (2014) Chinnaswamy Tiruppathi et al. NATURE IMMUNOLOGY
- The tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20) imposes a brake on antitumor activity of CD8 T cells
- (2014) M. Giordano et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Control of Steady-State Dendritic Cell Maturation and Immune Homeostasis
- (2013) Gianna Elena Hammer et al. Annual Review of Immunology
- Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML
- (2013) Li Shi et al. Cancer Cell International
- An Update on Autoinflammatory Diseases
- (2013) F. Ciccarelli et al. CURRENT MEDICINAL CHEMISTRY
- Dimerization and Ubiquitin Mediated Recruitment of A20, a Complex Deubiquitinating Enzyme
- (2013) Timothy T. Lu et al. IMMUNITY
- Linear ubiquitination-mediated NF- B regulation and its related disorders
- (2013) F. Tokunaga JOURNAL OF BIOCHEMISTRY
- Genome Engineering with Cre-loxP
- (2013) N. Maizels JOURNAL OF IMMUNOLOGY
- The complexity of NF-κB signaling in inflammation and cancer
- (2013) Bastian Hoesel et al. Molecular Cancer
- A20 in inflammation and autoimmunity
- (2013) Leen Catrysse et al. TRENDS IN IMMUNOLOGY
- Regulation of A20 and other OTU deubiquitinases by reversible oxidation
- (2013) Yogesh Kulathu et al. Nature Communications
- Reversible inactivation of deubiquitinases by reactive oxygen species in vitro and in cells
- (2013) Jin-Gu Lee et al. Nature Communications
- Regulation of NF-κB signaling by the A20 deubiquitinase
- (2012) Noula Shembade et al. Cellular & Molecular Immunology
- A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7
- (2012) Kelly Verhelst et al. EMBO JOURNAL
- Specific recognition of linear polyubiquitin by A20 zinc finger 7 is involved in NF-κB regulation
- (2012) Fuminori Tokunaga et al. EMBO JOURNAL
- NF- B, the first quarter-century: remarkable progress and outstanding questions
- (2012) M. S. Hayden et al. GENES & DEVELOPMENT
- The contribution of autophagy to lymphocyte survival and homeostasis
- (2012) Ian X. McLeod et al. IMMUNOLOGICAL REVIEWS
- Down-Regulation of A20 mRNA Expression in Peripheral Blood Mononuclear Cells from Patients with Systemic Lupus Erythematosus
- (2012) Di Li et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
- (2012) Luke Jostins et al. NATURE
- A miR-19 regulon that controls NF-κB signaling
- (2012) Michael P. Gantier et al. NUCLEIC ACIDS RESEARCH
- MicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20)
- (2012) S.-W. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular discrimination of responders and nonresponders to anti-TNFalpha therapy in rheumatoid arthritis by etanercept
- (2012) Dirk Koczan et al. ARTHRITIS RESEARCH & THERAPY
- miR-29c targets TNFAIP3, inhibits cell proliferation and induces apoptosis in hepatitis B virus-related hepatocellular carcinoma
- (2011) Chun-Mei Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Genetic relationships betweenA20/TNFAIP3, chronic inflammation and autoimmune disease
- (2011) Lars Vereecke et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- The Ubiquitin-Editing Protein A20 Prevents Dendritic Cell Activation, Recognition of Apoptotic Cells, and Systemic Autoimmunity
- (2011) Mirjam Kool et al. IMMUNITY
- TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
- (2011) Trilokraj Tejasvi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Direct, Noncatalytic Mechanism of IKK Inhibition by A20
- (2011) Brian Skaug et al. MOLECULAR CELL
- A20 (TNFAIP3) deficiency in myeloid cells triggers erosive polyarthritis resembling rheumatoid arthritis
- (2011) Mourad Matmati et al. NATURE GENETICS
- Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus
- (2011) Indra Adrianto et al. NATURE GENETICS
- Expression of A20 by dendritic cells preserves immune homeostasis and prevents colitis and spondyloarthritis
- (2011) Gianna Elena Hammer et al. NATURE IMMUNOLOGY
- Cytokine disturbances in systemic lupus erythematosus
- (2011) Noam Jacob et al. ARTHRITIS RESEARCH & THERAPY
- Association of the TNFAIP3 rs5029939 variant with systemic sclerosis in the European Caucasian population
- (2010) P. Dieude et al. ANNALS OF THE RHEUMATIC DISEASES
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study
- (2010) Gabor G. Illei et al. ARTHRITIS AND RHEUMATISM
- Expression, biological activities and mechanisms of action of A20 (TNFAIP3)
- (2010) Lynn Verstrepen et al. BIOCHEMICAL PHARMACOLOGY
- B cells lacking the tumor suppressor TNFAIP3/A20 display impaired differentiation and hyperactivation and cause inflammation and autoimmunity in aged mice
- (2010) Y. Chu et al. BLOOD
- A20 deficiency in B cells enhances B-cell proliferation and results in the development of autoantibodies
- (2010) Nadine Hövelmeyer et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Ubiquitin Modifying Enzyme A20 Restricts B Cell Survival and Prevents Autoimmunity
- (2010) Rita M. Tavares et al. IMMUNITY
- African-Derived Genetic Polymorphisms in TNFAIP3 Mediate Risk for Autoimmunity
- (2010) J. P. Lodolce et al. JOURNAL OF IMMUNOLOGY
- Ubiquitin Binding to A20 ZnF4 Is Required for Modulation of NF-κB Signaling
- (2010) Ivan Bosanac et al. MOLECULAR CELL
- O-Glycosylation Regulates Ubiquitination and Degradation of the Anti-Inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic ApoE-Null Mice
- (2010) Gautam V. Shrikhande et al. PLoS One
- Inhibition of NF- B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes
- (2010) N. Shembade et al. SCIENCE
- Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis
- (2009) Thomas Dörner et al. AUTOIMMUNITY REVIEWS
- The NF- B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
- (2009) U. Novak et al. BLOOD
- TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
- (2009) K. Honma et al. BLOOD
- Receptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
- (2009) Sudan He et al. CELL
- Meta-analysis and imputation identifies a 109 kb risk haplotype spanning TNFAIP3 associated with lupus nephritis and hematologic manifestations
- (2009) J S Bates et al. GENES AND IMMUNITY
- Toll-like receptors - sentries in the B-cell response
- (2009) Isabelle Bekeredjian-Ding et al. IMMUNOLOGY
- A20 takes on tumors: tumor suppression by an ubiquitin-editing enzyme
- (2009) Barbara A. Malynn et al. JOURNAL OF EXPERIMENTAL MEDICINE
- TNFAIP3(A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
- (2009) Roland Schmitz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A20 Negatively Regulates T Cell Receptor Signaling to NF- B by Cleaving Malt1 Ubiquitin Chains
- (2009) M. Duwel et al. JOURNAL OF IMMUNOLOGY
- Interleukin 6 (IL-6) Deficiency Delays Lupus Nephritis in MRL-Faslpr Mice: The IL-6 Pathway as a New Therapeutic Target in Treatment of Autoimmune Kidney Disease in Systemic Lupus Erythematosus
- (2009) H. CASH et al. JOURNAL OF RHEUMATOLOGY
- Involvement of linear polyubiquitylation of NEMO in NF-κB activation
- (2009) Fuminori Tokunaga et al. NATURE CELL BIOLOGY
- Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
- (2009) Rajan P Nair et al. NATURE GENETICS
- Analysis of TNFAIP3, a feedback inhibitor of nuclear factor-κB and the neighbor intergenic 6q23 region in rheumatoid arthritis susceptibility
- (2009) Rebeca Dieguez-Gonzalez et al. ARTHRITIS RESEARCH & THERAPY
- Inflammatory cardiac valvulitis in TAX1BP1-deficient mice through selective NF-κB activation
- (2008) Hidekatsu Iha et al. EMBO JOURNAL
- Signature biomarkers in Crohn's disease: toward a molecular classification
- (2008) R Arsenescu et al. Mucosal Immunology
- ABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development
- (2008) Shigeru Oshima et al. NATURE
- Multiple polymorphisms in the TNFAIP3 region are independently associated with systemic lupus erythematosus
- (2008) Stacy L Musone et al. NATURE GENETICS
- T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20
- (2008) Beatrice Coornaert et al. NATURE IMMUNOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started